Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2023The Lancet HaematologyOpen Access

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAnnie CowanHarvard UniversityFFFederico FerrariUniversity of GroningenSFSamuel S. FreemanMemorial Sloan Kettering Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cowan et al. (2023) studied this question.

synapsesocial.com/papers/6a809d3f2ea91e47663d6736https://doi.org/10.1016/s2352-3026(22)00386-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence of Monoclonal Gammopathy of Undetermined Significance2006 · 1,434 citations
  2. 2Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring Monoclonal Gammopathies2011 · 75 citations
  3. 3Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria2018 · 308 citations
  4. 4International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)2020 · 296 citations
  5. 5Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events2021 · 26 citations